This article is more than 5 years old. Information may no longer be current.

B&L posts 7% sales gain for quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ROCHESTER, N.Y. — Worldwide net sales for Bausch & Lomb increased 7% to $608.3 million in the second quarter of 2005, up from $566.5 million in the second quarter of 2004, the company announced in a press release.

The sales increase was greatest in Europe, the Middle East and Africa, with contact lenses showing the most growth, the company stated. Revenues in the United States were $226.5 million, up less than 2% from the previous year’s second quarter. The U.S. market represents 37% of the company’s total sales, the press release said.

Growth in cataract and vitreoretinal products was led by B&L’s IOL and phacoemulsification lines, the release said. In constant currency, IOL sales growth was 9%, with double-digit gains for the SofPort and Akreos foldable IOL models.

Refractive surgical growth was attributed to a 16% increase in sales of per-procedure cards used in LASIK and increased service revenue. This was offset by “somewhat” lower equipment sales, the release said.